Clinical trial
Fructose-induced Hepatic De Novo Lipogenesis in South Asians
NCT01562782 is registered in ClinicalTrials.gov with The Rogosin Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fructose-induced Hepatic De Novo Lipogenesis in South Asians
- Lead sponsor
- The Rogosin Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 2, 2012
- Completion date
- October 10, 2013
- Enrollment
- 39 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular disease, diabetes, dyslipidemia, elevated triglycerides